The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Correlation of PSMA ADC exposure with reduction in tumor growth rate determined using serial PSA measurements from a phase I clinical trial.
Yakov Rotshteyn
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
Francois Mercier
Employment or Leadership Position - Pharsight
Rene Bruno
Employment or Leadership Position - Pharsight
Nancy Stambler
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
Robert Joseph Israel
Employment or Leadership Position - Progenics
Stock Ownership - Progenics
Vivien Wong
Employment or Leadership Position - Progenics
Stock Ownership - Progenics